title: [Surgical therapy of liver and bile duct tumors].
abstract: The most effective surgical therapy of primary liver cancer (HCC) or proximal bile duct cancer (BDC) is radical resection, but only 20% of the patients will undergo this procedure, because the remaining patients in the advanced tumour-stage or cirrhosis can be given palliative treatment only (chemo-embolisation for HCC, endoscopic or percutaneous draining with or without iridium-after-loading for BDC) or a liver transplantation (LTX), though under immunosuppression an early recurrence of the tumour is frequent. One-year survival after resection because of HCC without cirrhosis is represented by a figure of 80%, whereas with cirrhosis it is 18%; 3 years after LTX, 26% of patients are alive. Three-year survival in untreated BDC is 24%, after resection of the hilum 42%, after LTX 40%.
authors.affiliation: Klinik für Allgemeinchirurgie der Eberhard-Karls-Universität Tübingen.
authors.forename: R
authors.initials: R
authors.lastname: Viebahn
authors.forename: W
authors.initials: W
authors.lastname: Lauchart
authors.forename: H D
authors.initials: HD
authors.lastname: Becker
mesh_terms: D001650:Bile Duct Neoplasms / Q000473:pathology / Q000601:surgery*; D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000601:surgery*; D005500:Follow-Up Studies; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000601:surgery*; D016031:Liver Transplantation; D009367:Neoplasm Staging
vernacular_title: Chirurgische Therapie der Leber- und Gallenwegstumoren.